{"DataElement":{"publicId":"6831684","version":"1","preferredName":"Therapeutic Procedure Osteoclast Targeted Therapy Use Not Used Reason","preferredDefinition":"The reason for not using osteoclast targeted therapy.","longName":"6831423v1.0:6831679v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6831423","version":"1","preferredName":"Therapeutic Procedure Osteoclast Targeted Therapy Use","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._A large, multinucleated cell that secretes bone-degrading enzymes in the processes of normal bone remodeling and pathological bone loss. Osteoclasts are derived from macrophages._A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments._To put into action or service.","longName":"2512834v1.0:6831421v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2512834","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89860A-B9D6-3798-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6831421","version":"1","preferredName":"Osteoclast Targeted Therapy Use","preferredDefinition":"A large, multinucleated cell that secretes bone-degrading enzymes in the processes of normal bone remodeling and pathological bone loss. Osteoclasts are derived from macrophages.:A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments.:To put into action or service.","longName":"C12570:C93352:C95018","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoclast","conceptCode":"C12570","definition":"A large, multinucleated cell that secretes bone-degrading enzymes in the processes of normal bone remodeling and pathological bone loss. Osteoclasts are derived from macrophages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Targeted Therapy","conceptCode":"C93352","definition":"A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Use","conceptCode":"C95018","definition":"To put into action or service.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E86AB01-19B1-027B-E053-F662850A291E","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E86AB01-19C2-027B-E053-F662850A291E","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"MORENOC","dateModified":"2020-01-09","changeDescription":"1/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6831679","version":"1","preferredName":"Ostoclast Targeted Therapy Not Used Reason","preferredDefinition":"An explanation of the cause for not using Osteoclast targeted therapy.","longName":"6831679v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"500","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Dental condition or need for dental intervention","valueDescription":"Dental Disorder Or Need Dental Intervention or Procedure","ValueMeaning":{"publicId":"6824817","version":"1","preferredName":"Dental Disorder Or Need Dental Intervention or Procedure","longName":"6824817","preferredDefinition":"A non-neoplastic or neoplastic (benign or malignant) disorder affecting the teeth.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Anything that is necessary but lacking; the psychological feature that arouses an organism to action toward a desired goal; the reason for the action; that which gives purpose and direction to behavior.: Pertaining to a tooth or teeth, or to odontology.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dental Disorder","conceptCode":"C35077","definition":"A non-neoplastic or neoplastic (benign or malignant) disorder affecting the teeth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Need","conceptCode":"C41204","definition":"Anything that is necessary but lacking; the psychological feature that arouses an organism to action toward a desired goal; the reason for the action; that which gives purpose and direction to behavior.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dental","conceptCode":"C41136","definition":"Pertaining to a tooth or teeth, or to odontology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E6D9BD3-0391-0FDF-E053-F662850A61CB","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E882254-E4BD-169E-E053-F662850A1314","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Hypersensitivity to drug formulation","valueDescription":"Drug Hypersensitivity Syndrome To Drug Formulation Process","ValueMeaning":{"publicId":"6824818","version":"1","preferredName":"Drug Hypersensitivity Syndrome To Drug Formulation Process","longName":"6824818","preferredDefinition":"A potentially life-threatening hypersensitivity reaction to a pharmacologic substance that is characterized by rash, lymphadenopathy, fever, hematologic abnormalities and involvement of one or more internal organs.: Used as a function word to indicate direction, purpose, or movement.: The act or process of developing or preparing a mixture of ingredients to create a desired end drug product, such as a specific flavor, aroma, or polymer; or the desired final drug product itself; also, a listing of the ingredients and composition of the dosage form.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Hypersensitivity Syndrome","conceptCode":"C112208","definition":"A potentially life-threatening hypersensitivity reaction to a pharmacologic substance that is characterized by rash, lymphadenopathy, fever, hematologic abnormalities and involvement of one or more internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Drug Formulation Process","conceptCode":"C15653","definition":"The act or process of developing or preparing a mixture of ingredients to create a desired end drug product, such as a specific flavor, aroma, or polymer; or the desired final drug product itself; also, a listing of the ingredients and composition of the dosage form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E6D9BD3-03B8-0FDF-E053-F662850A61CB","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E882254-E4C8-169E-E053-F662850A1314","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Hypocalcemia","valueDescription":"Hypocalcemia","ValueMeaning":{"publicId":"2751399","version":"1","preferredName":"Hypocalcemia","longName":"2751399","preferredDefinition":"Hypocalemia; lower than normal levels of calcium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypocalcemia","conceptCode":"C37973","definition":"Lower than normal levels of calcium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A38-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E882254-E4D3-169E-E053-F662850A1314","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Hypophosphatemia","valueDescription":"Hypophosphatemia","ValueMeaning":{"publicId":"2751402","version":"1","preferredName":"Hypophosphatemia","longName":"2751402","preferredDefinition":"Hypophosphatemia; lower than normal levels of phosphates in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypophosphatemia","conceptCode":"C37977","definition":"Lower than normal levels of phosphates in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0AA7-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E882254-E4DE-169E-E053-F662850A1314","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Renal impairment","valueDescription":"Renal Impairment","ValueMeaning":{"publicId":"2573567","version":"1","preferredName":"Renal Impairment","longName":"2573567v1.00","preferredDefinition":"Diminished kidney function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Impairment","conceptCode":"C114592","definition":"Diminished kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC6C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E882254-E4E9-169E-E053-F662850A1314","beginDate":"2019-07-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E882254-E4A7-169E-E053-F662850A1314","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"MORENOC","dateModified":"2020-01-09","changeDescription":"1/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"reason no osteoclast targeted","type":"Preferred Question Text","description":"reason no osteoclast targeted therapy use","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E887539-FE3E-1396-E053-F662850A6FC2","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"MORENOC","dateModified":"2020-01-09","changeDescription":"1/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}